Los Angeles Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.8K Hold
2,165
﹤0.01% 1490
2025
Q4
$48.9K Sell
2,165
-44,398
-95% -$966K ﹤0.01% 1605
2025
Q3
$938K Buy
+46,563
New +$780K ﹤0.01% 721
2025
Q1
Sell
-10,090
Closed -$122K 1125
2024
Q4
$122K Sell
10,090
-1,670
-14% -$21.9K ﹤0.01% 1083
2024
Q3
$173K Hold
11,760
﹤0.01% 1133
2024
Q2
$170K Buy
+11,760
New +$188K ﹤0.01% 1136
2021
Q3
Sell
-12,298
Closed -$427K 1503
2021
Q2
$427K Sell
12,298
-60,305
-83% -$1.99M ﹤0.01% 1249
2021
Q1
$2.14M Buy
72,603
+36,073
+99% +$1.11M 0.01% 598
2020
Q4
$1.12M Sell
36,530
-10,540
-22% -$322K ﹤0.01% 888
2020
Q3
$1.31M Buy
+47,070
New +$1.19M 0.01% 714
2019
Q3
Sell
-13,170
Closed -$445K 1287
2019
Q2
$445K Buy
+13,170
New +$428K ﹤0.01% 1077

Other funds holding ELAN

Los Angeles Capital Management's ELAN Position: Q1 2026 in Review

Los Angeles Capital Management held its Elanco Animal Health (ELAN) position steady in Q1 2026 at 2,165 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Los Angeles Capital Management first reported a position in ELAN in Q2 2019 and has held it in 11 quarters since. The position peaked at $2.14M in Q1 2021. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Los Angeles Capital Management held 2,165 shares of Elanco Animal Health worth $51.8K as of Q1 2026.
  • Los Angeles Capital Management left its Elanco Animal Health share count unchanged in Q1 2026.
  • Elanco Animal Health made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1490 holding.
  • Los Angeles Capital Management first reported a position in Elanco Animal Health in Q2 2019 and has held it in 11 quarters since.
  • Los Angeles Capital Management's Elanco Animal Health position peaked at $2.14M in Q1 2021.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.